Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 4/20 | 0.54 |
| ▸ | CETP | P11597 | 1/20 | 0.48 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
| ▸ | GJB2 | P29033 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7532142 | 0.97 | TLR4 (0.56) | TLR4CETPSELP | |
| SCHEMBL509203 | 0.97 | TLR4 (0.50) | TLR4CETPSELP | |
| SCHEMBL2959757 | 0.94 | TLR4 (0.54) | TLR4CETPSELPGJB2 | |
| SCHEMBL4185270 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL3393533 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4181285 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4199470 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4185394 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL3388849 | 0.93 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4187653 | 0.91 | FFAR1 (0.47) | TLR4CETPSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2314351-B1 | Hair dye agent with improved skin tolerance | HENKEL AG & CO KGAA (DE) | 2014-12-17 | — | — | EP | claimed |
| US-20230217875-A1 | IN VITRO EMBRYO RESCUE | BASF AGRICULTURAL SOLUTIONS US LLC | 2023-07-13 | — | — | US | disclosed |
| EP-4161254-A1 | IN VITRO EMBRYO RESCUE | BASF Agricultural Solutions Seed US LLC (US) | 2023-04-12 | — | — | EP | disclosed |
| WO-2022147470-A1 | IMPROVED TOPICAL CANNABINOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME | KIMBERLY CLARK CO (US) | 2022-07-07 | — | — | WO | disclosed |
| WO-2021251860-A1 | IN VITRO EMBRYO RESCUE | KOEHLER CLAUDIA (SE) | 2021-12-16 | — | — | WO | disclosed |
| CN-101687167-B | W/O/W type emulsified composition | NISSHIN OILLIO GROUP LTD | 2012-10-03 | — | — | CN | disclosed |
| US-7754864-B2 | Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20100099646-A1 | W/O/W EMULSION COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2172263-A1 | W/O/W EMULSION COMPOSITION | The Nisshin OilliO Group, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| CN-101687167-A | W/O/W type emulsified composition | NISSHIN OILLIO GROUP LTD | 2010-03-31 | — | — | CN | disclosed |
| US-20090098172-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | KAO CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20070292462-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | KAO CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | IKEMOTO TAKESHI | 2007-07-12 | — | — | US | disclosed |
| US-20060052318-A1 | Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1550667-A1 | TYROSINASE ACTIVITY CONTROLLING AGENTS, PROCESS FOR PRODUCING THE SAME AND EXTERNAL PREPARATIONS CONTAINING THE SAME | National Institute of Advanced Industrial Science and Technology (JP) | 2005-07-06 | — | — | EP | disclosed |
| US-20040022819-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | KAO CORPORATION (JP) | 2004-02-05 | — | — | US | disclosed |
| US-6497898-B1 | STABILITY, DRUG AND COSMETIC DELIVERY | KANEBO LTD (JP) | 2002-12-24 | — | — | US | disclosed |
| EP-0729781-B1 | LIPOSOME COMPRISING A MEMBRANE WALL COMPOSED OF A TREHALOSE FATTY ACID ESTER | KANEBO LTD (JP) | 2002-08-07 | — | — | EP | disclosed |
| EP-0729781-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | Ikemoto, Takeshi (JP) | 1996-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292462-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | TLR4 477/4885CETP 11/4885SELP 3602/4885 |
| US-20060052318-A1 | Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same | TYR, GAP43, CNTN1 | TLR4 4809/4885CETP 2583/4885SELP 4181/4885 |
| US-20040022819-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | TLR4 451/4885CETP 16/4885SELP 3788/4885 |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | TLR4 477/4885CETP 11/4885SELP 3602/4885 |
| US-20090098172-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | TREH, LIPA, SGMS1 | TLR4 513/4885CETP 10/4885SELP 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.